- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.18 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID
- 5 x EDO: 1,2-ETHANEDIOL
EDO.2: 10 residues within 4Å:- Chain A: T.190, P.191, Y.192, W.193, M.194
- Chain B: R.151, D.152, I.153, K.154, S.215
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:P.191, A:W.193, B:D.152, B:I.153
EDO.3: 7 residues within 4Å:- Chain A: K.61, D.152, D.170, G.172, I.173, Q.176
- Ligands: DMS.6
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.170
- Water bridges: A:G.172
EDO.4: 7 residues within 4Å:- Chain A: G.39, T.42, Y.43, Q.115, D.116, Q.119
- Ligands: 01.7
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:T.42, A:Y.43, A:Y.43, A:Q.115
EDO.12: 6 residues within 4Å:- Chain B: Y.32, D.51, S.54, D.56, V.58, H.93
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:Y.32, B:D.51, B:D.51, B:H.93
EDO.13: 6 residues within 4Å:- Chain B: A.87, N.88, E.135, E.165, V.166, R.167
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:E.135, B:R.167, B:R.167
- Water bridges: B:N.88, B:E.165
- 3 x DMS: DIMETHYL SULFOXIDE
DMS.5: 9 residues within 4Å:- Chain A: K.61, E.77, L.81, V.90, M.106, A.169, D.170, F.171
- Ligands: 01.7
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:E.77, A:D.170, A:F.171
- Salt bridges: A:E.77
DMS.6: 7 residues within 4Å:- Chain A: T.42, Y.43, G.44, K.61, D.170
- Ligands: EDO.3, 01.7
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.61
- Salt bridges: A:D.170
DMS.14: 9 residues within 4Å:- Chain A: W.193
- Chain B: Q.115, Y.118, Q.119, E.222, L.226, Q.227, P.228, F.231
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Y.118
- pi-Cation interactions: B:F.231
- 1 x 01: (9S)-2-{[(6P)-8-amino-6-(5-amino-4-methylpyridin-3-yl)-7-fluoroisoquinolin-3-yl]amino}-6-methyl-5,6-dihydro-4H-pyrazolo[1,5-d][1,4]diazepin-7(8H)-one
01.7: 25 residues within 4Å:- Chain A: Q.36, L.38, G.39, Y.43, V.46, A.59, K.61, V.90, M.106, E.107, F.108, C.109, G.110, A.111, G.112, S.113, D.116, A.156, N.157, L.159, A.169, D.170
- Ligands: EDO.4, DMS.5, DMS.6
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:L.38, A:Y.43, A:Y.43, A:A.59, A:L.159, A:L.159
- Hydrogen bonds: A:G.39, A:K.61, A:E.107, A:C.109, A:C.109, A:N.157, A:D.170
- 1 x NA: SODIUM ION
- 1 x PEG: DI(HYDROXYETHYL)ETHER
- 1 x 02: (4S,5R,7R,11aP)-10-{[(3R)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl}-N~3~-methyl-6,7-dihydro-5H-5,7-methanoimidazo[2,1-a][2]benzazepine-2,3-dicarboxamide
02.15: 27 residues within 4Å:- Chain B: L.38, G.39, G.40, G.41, T.42, V.46, A.59, K.61, E.77, L.81, I.89, V.90, A.91, Y.92, I.104, M.106, E.107, F.108, C.109, G.110, A.111, G.112, L.159, A.169, D.170, F.171, G.172
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:V.46, B:L.81, B:I.104, B:D.170
- Hydrogen bonds: B:E.77, B:E.107, B:C.109, B:C.109, B:D.170, B:F.171
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tellis, J.C. et al., Discovery of GNE-6893, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of HPK1. Acs Med.Chem.Lett. (2024)
- Release Date
- 2024-10-02
- Peptides
- Mitogen-activated protein kinase kinase kinase kinase 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.18 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID
- 5 x EDO: 1,2-ETHANEDIOL
- 3 x DMS: DIMETHYL SULFOXIDE
- 1 x 01: (9S)-2-{[(6P)-8-amino-6-(5-amino-4-methylpyridin-3-yl)-7-fluoroisoquinolin-3-yl]amino}-6-methyl-5,6-dihydro-4H-pyrazolo[1,5-d][1,4]diazepin-7(8H)-one
- 1 x NA: SODIUM ION
- 1 x PEG: DI(HYDROXYETHYL)ETHER
- 1 x 02: (4S,5R,7R,11aP)-10-{[(3R)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl}-N~3~-methyl-6,7-dihydro-5H-5,7-methanoimidazo[2,1-a][2]benzazepine-2,3-dicarboxamide
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tellis, J.C. et al., Discovery of GNE-6893, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of HPK1. Acs Med.Chem.Lett. (2024)
- Release Date
- 2024-10-02
- Peptides
- Mitogen-activated protein kinase kinase kinase kinase 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B